The ablastin phenomenon: inhibition of membrane function.
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000818:Animals; D000906:Antibodies; D000941:Antigens; D001666:Binding Sites, Antibody; D001692:Biological Transport; D002455:Cell Division; D002462:Cell Membrane / Q000378:metabolism; D002463:Cell Membrane Permeability; D004247:DNA / Q000096:biosynthesis; D003847:Deoxyglucose / Q000378:metabolism; D003907:Dexamethasone / Q000494:pharmacology; D000939:Epitopes; D005947:Glucose / Q000378:metabolism; D007165:Immunosuppression Therapy; D010042:Ouabain / Q000494:pharmacology; D051381:Rats; D014350:Trypanosoma lewisi / Q000254:growth & development / Q000276:immunology* / Q000378:metabolism; D014352:Trypanosomiasis / Q000276:immunology
D000906:Antibodies; D000941:Antigens; D000939:Epitopes; D010042:Ouabain; D003907:Dexamethasone; D004247:DNA; D003847:Deoxyglucose; D000251:Adenosine Triphosphatases; D005947:Glucose